Low-dose PEM shows promise in breast cancer detection
Low-dose positron emission mammography (PEM) can detect invasive breast cancer in a feasible manner, according to research published February 9 in Radiology: Imaging Cancer.
A team led by Vivianne Freitas, MD, from the University of Toronto found that PEM performed comparably to MRI in breast cancer detection and could serve as a supplemental imaging method for evaluating dense breasts.
"This groundbreaking imaging technique presents a compelling alternative, mirroring the clinical utility of traditional mammography and MRI but utilizing considerably lower doses of radiation when compared with previously molecular breast...
Source: AuntMinnie.com Headlines - February 9, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Womens Imaging Source Type: news
RSNA: Novel Technique Has Potential to Transform Breast Cancer Detection
An innovative breast imaging technique provides high sensitivity for detecting cancer while significantly reducing the likelihood of false positive results, according to a study published today in Radiology: Imaging Cancer, a journal of the Radiological Society of North America (RSNA).... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 9, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news
Hyperbaric Oxygen Therapy Shows Some Benefit After Breast Cancer Irradiation
(MedPage Today) -- Hyperbaric oxygen therapy (HBOT) was not effective for reducing pain, but was effective for reducing fibrosis, among women with late local toxic effects after irradiation for breast cancer, a Dutch randomized study showed.
In... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 9, 2024 Category: Hematology Source Type: news
PreludeDx Appoints Chris Emery, VP of Strategic Marketing and Business Development
LAGUNA HILLS, Calif., Feb. 8, 2024 -- (Healthcare Sales & Marketing Network) -- Prelude Corporation (PreludeDx), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced the appointment of Chris Emery to the... Diagnostics, Oncology, Personnel PreludeDx, DecisionTree (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 8, 2024 Category: Pharmaceuticals Source Type: news
Screening and Treatment Reduce Breast Cancer Mortality Screening and Treatment Reduce Breast Cancer Mortality
Simulation models indicate that breast cancer screening and treatment were associated with a 58% reduction in mortality, based on data collected between 1975 and 2019.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 8, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Vid wrapper: Researcher speaks on MyChart Mobile tool with AuntMinnie.com
Researchers recently had results published showing the efficacy of an online tool for women to better understand their breast cancer screening results, including what their mammograms mean.Seetharam Chadalavada, MD, from the University of Cincinnati co-authored the paper, published in the Journal of the American College of Radiology, and spoke with AuntMinnie.com on how a human-centered design framework led to the tool's creation. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 7, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Womens Imaging Source Type: news
Researcher speaks on MyChart Mobile tool with AuntMinnie.com
Researchers recently had results published showing the efficacy of an online tool for women to better understand their breast cancer screening results, including what their mammograms mean.Seetharam Chadalavada, MD, from the University of Cincinnati co-authored the paper, published in the Journal of the American College of Radiology, and spoke with AuntMinnie.com on how a human-centered design framework led to the tool's creation. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 7, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Womens Imaging Source Type: news
Race Can Affect Breast Cancer Test for Predicting Chemo Benefit
TUESDAY, Feb. 6, 2024 -- The 21-gene breast recurrence score (RS) is valid for predicting chemotherapy benefit for non-Hispanic Black (NHB), Hispanic, and non-Hispanic White (NHW) women with estrogen receptor (ER)-positive, axillary node-negative... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 6, 2024 Category: Pharmaceuticals Source Type: news
As a breast cancer survivor, I wanted a partner who saw me for more than my missing parts
Opening herself up to dating after breast cancer and reconstructive surgery made Victoria Cassidy vulnerable to heartbreak. But she found her way to love and happiness, with someone who saw her as whole and complete. (Source: CBC | Health)
Source: CBC | Health - February 6, 2024 Category: Consumer Health News Tags: News/Canada/Saskatchewan Source Type: news
Editorial criticizes breast screening guidelines, ACR responds
An editorial criticizing the U.S. Preventive Services Task Force (USPSTF) breast cancer screening guidelines has drawn the ire of the American College of Radiology (ACR). The editorial, published February 5 in the Annals of Internal Medicine, stated that the updated USPSTF guidelines issued in 2023 could create more confusion among women considering undergoing breast cancer screening and make way for more harm tied to screening. “The USPSTF risks abandoning its role in setting the standard for using evidence and sound judgment to make medical decisions,” wrote Russell Harris, MD, a former USPSTF member, in his ed...
Source: AuntMinnie.com Headlines - February 6, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Associations Breast Imaging Source Type: news
CEM image quality unaffected by iron particles from tracers
Low-dose iron oxide tracers impact the quality of breast MR images, but not that of contrast-enhanced mammography (CEM), a study published February 5 in Surgical Oncology found.
Researchers led by Elisabeth van Haaren from the Zuyderland Medical Centre in Sittard-Geleen, the Netherlands, found that even after a low-dose injection (1 ml) of superparamagnetic iron oxide (SPIO) tracer, iron remnants stay behind in the breast tissue and disturb all MR images. However, they also observed no such effect on CEM images.
“CEM could be valuable alternative if additional imaging is needed in the follow-up of breast cancer,” van...
Source: AuntMinnie.com Headlines - February 6, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Clinical News Subspecialties MRI Ultrasound Breast Imaging Source Type: news
CEM image quality unaffected by iron particles from tracers
Low-dose iron oxide tracers impact the quality of breast MR images, but not that of contrast-enhanced mammography (CEM), a study published February 5 in Surgical Oncology found.
Researchers led by Elisabeth van Haaren from the Zuyderland Medical Centre in Sittard-Geleen, the Netherlands, found that even after a low-dose injection (1 ml) of superparamagnetic iron oxide (SPIO) tracer, iron remnants stay behind in the breast tissue and disturb all MR images. However, they also observed no such effect on CEM images.
“CEM could be valuable alternative if additional imaging is needed in the follow-up of breast cancer,” van...
Source: AuntMinnie.com Headlines - February 6, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Clinical News Subspecialties MRI Ultrasound Breast Imaging Source Type: news
ChatGPT shows promise for improving breast cancer education materials
ChatGPT can simplify responses to questions about breast cancer prevention and screening by improving the reading ease and readability of educational materials while maintaining overall clinical appropriateness, researchers have found.The findings could translate to better support for patients navigating breast cancer screening, wrote a team led by Hana Haver, MD, of the University of Maryland Medical Intelligent Imaging Center in Baltimore. The study findings were published February 2 in Radiology: Imaging Cancer."In the context of breast cancer screening, increasing the readability of patient-facing material has been sho...
Source: AuntMinnie.com Headlines - February 5, 2024 Category: Radiology Tags: Clinical News Subspecialties Womens Imaging Breast Breast Imaging Source Type: news
Cancer screening hasn't rebounded to prepandemic levels
Preventive health screenings, including those for screening mammography, have not rebounded to pre-COVID-19 pandemic levels, a new study published February 2 in JAMA Health Forum found.
Researchers led by Rishi Wadhera, MD, from Beth Israel Deaconess Medical Center in Boston found that eligible adults were significantly less likely to receive breast cancer screening and other types of health screening in 2021 compared with 2019.
“These findings support the need for public health efforts to increase the use of preventive health screenings among eligible U.S. adults,” Wadhera and co-authors wrote.
Previous research ha...
Source: AuntMinnie.com Headlines - February 2, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Breast Imaging Source Type: news
Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer
(MedPage Today) -- Artificial intelligence-driven analysis of blood samples showed potential for early diagnosis of ovarian cancer with 93% accuracy. (Georgia Tech, Gynecologic Oncology)
Hologic announced FDA clearance of a digital cytology system... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 2, 2024 Category: Hematology Source Type: news
